✦ LIBER ✦

P917. Taxol and fluorouracil as second line chemotherapy for metastatic breast cancer

✍ Scribed by A. Fornasiero; C. Ghiotto; O. Daniele; P. D'Amanzo; S.M.L. Aversa; V. Chiarion Sileni; M.V. Fiorentino

Book ID: 114316918
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 147 KB
Volume: 6
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(97)90088-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment Choices for Second-Line Chemot

Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer

✍ Christoph C. Zielinski 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 55 KB

Amonafide as first-line chemotherapy for

Amonafide as first-line chemotherapy for metastatic breast cancer

✍ Kornek, G; Raderer, M; Depisch, D; Haider, K; Fazeny, B; Dittrich, C; Scheithaue 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 403 KB

374 Vinorelbine, 5 fluorouracil, leucovo

374 Vinorelbine, 5 fluorouracil, leucovorin and cyclophosphamide as first line chemotherapy in metastatic breast cancer (MBC)

✍ P. Turpin; A. Lluch; M.H. Closon; G. Gruia; A. Llombart; R. Fernandez; P.M. Delg 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Single agent taxol (TAX) as second-line

Single agent taxol (TAX) as second-line chemotherapy for patients with metastatic non-small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Second-line chemotherapy for metastatic

Second-line chemotherapy for metastatic breast cancer including quality of life issues

✍ A.U. Buzdar; G.N. Hortobagyi; D. Frye; V. Valero 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 918 KB

Combination chemotherapy for metastatic

Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate

✍ Ambrose Aboud; Aman U. Buzdar; Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. B 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Twenty-nine patients with metastatic breast cancer were treated with fluorouracil, adriamycin, cyclophosphamide (FAC), and methotrexate (MTX), with or without leukovorin rescue. Of 24 evaluable patients, one achieved a complete remission and 17 had partial responses. The overall objective response r